Rekindling RNAi therapy: materials design requirements for in vivo siRNA delivery

B Kim, JH Park, MJ Sailor - Advanced materials, 2019 - Wiley Online Library
With the recent FDA approval of the first siRNA‐derived therapeutic, RNA interference
(RNAi)‐mediated gene therapy is undergoing a transition from research to the clinical …

siRNA versus miRNA as therapeutics for gene silencing

JKW Lam, MYT Chow, Y Zhang, SWS Leung - Molecular Therapy-Nucleic …, 2015 - cell.com
Discovered a little over two decades ago, small interfering RNAs (siRNAs) and microRNAs
(miRNAs) are noncoding RNAs with important roles in gene regulation. They have recently …

Preclinical and clinical development of siRNA-based therapeutics

G Ozcan, B Ozpolat, RL Coleman, AK Sood… - Advanced drug delivery …, 2015 - Elsevier
The discovery of RNA interference, first in plants and Caenorhabditis elegans and later in
mammalian cells, led to the emergence of a transformative view in biomedical research …

Non-viral gene therapy: Gains and challenges of non-invasive administration methods

M Foldvari, DW Chen, N Nafissi, D Calderon… - Journal of Controlled …, 2016 - Elsevier
Gene therapy is becoming an influential part of the rapidly increasing armamentarium of
biopharmaceuticals for improving health and combating diseases. Currently, three gene …

Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery

CN Landen Jr, A Chavez-Reyes, C Bucana… - Cancer research, 2005 - AACR
Inducing destruction of specific mRNA using small interfering RNA (siRNA) is a powerful tool
in analysis of protein function, but its use as a therapeutic modality has been limited by …

Journey of siRNA: clinical developments and targeted delivery

RR Nikam, KR Gore - Nucleic acid therapeutics, 2018 - liebertpub.com
Since the evolutionary discovery of RNA interference and its utilization for gene knockdown
in mammalian cell, a remarkable progress has been achieved in small interfering RNA …

[HTML][HTML] RNA therapeutics: RNAi and antisense mechanisms and clinical applications

J Chery - Postdoc journal: a journal of postdoctoral research and …, 2016 - ncbi.nlm.nih.gov
RNA therapeutics refers to the use of oligonucleotides to target primarily ribonucleic acids
(RNA) for therapeutic efforts or in research studies to elucidate functions of genes …

Luteolin and abyssinone II as potential inhibitors of SARS-CoV-2: An in silico molecular modeling approach in battling the COVID-19 outbreak

MMAK Shawan, SK Halder, MA Hasan - Bulletin of the National Research …, 2021 - Springer
Background At present, the entire world is in a war against COVID-19 pandemic which has
gradually led us toward a more compromised “new normal” life. SARS-CoV-2, the …

Functional analysis of human microtubule-based motor proteins, the kinesins and dyneins, in mitosis/cytokinesis using RNA interference

C Zhu, J Zhao, M Bibikova, JD Leverson… - Molecular biology of …, 2005 - Am Soc Cell Biol
Microtubule (MT)-based motor proteins, kinesins and dyneins, play important roles in
multiple cellular processes including cell division. In this study, we describe the generation …

RNA interference: from gene silencing to gene-specific therapeutics

RKM Leung, PA Whittaker - Pharmacology & therapeutics, 2005 - Elsevier
In the past 4 years, RNA interference (RNAi) has become widely used as an experimental
tool to analyse the function of mammalian genes, both in vitro and in vivo. By harnessing an …